Australia is one of the highest users of antibiotics in the developed world. So when do we actually need antibiotics to treat an infection? And when should we avoid them?
Developing new antibiotics is important in the fight against antibiotic resistance. But we also need to use the antibiotics we already have much more wisely – GPs play a major role in this.
Researchers uncovered the foundations of biology by using E. coli as a model organism. But over-reliance on this microbe can lead to knowledge blind spots with implications for antibiotic resistance.
Wastewater treatment plants receive wastewater from a variety of sources. This makes them useful proxies for determining the burden of antimicrobial resistance in communities.
Antibiotic resistance has contributed to millions of deaths worldwide. Research suggests that any bacteria can develop antibiotic tolerance, and possibly resistance, when pushed to their limits.
Bacterial infections are a growing global challenge. This is due to antibiotic-resistant bacteria, and researchers are turning to AI to develop new drugs.
Most antibiotics work by killing bacteria. But this also helps them to become resistant. If we render bacteria harmless to us, rather than kill them, it’s a win-win.
Claire Guinat, Swiss Federal Institute of Technology Zurich; Etthel Windels, Swiss Federal Institute of Technology Zurich, and Sarah Nadeau, Swiss Federal Institute of Technology Zurich
After a nose swab tests positive for a virus or bacteria, scientists can use the sample’s genetic sequence to figure out where and when the pathogen emerged and how fast it’s changing.
Antibiotic resistance is one of the biggest public health threats in the world. New research, however, may have found a way to keep up with rapidly evolving bacteria.
As the world has focused on the COVID-19 pandemic, other microbial foes are waging war on humans. Antibiotic-resistant bacteria pose a growing threat. But viruses may defeat them.
Antimicrobial resistance is a public health and economic disaster waiting to happen. If we do not address this threat, by 2050 more people will die from drug-resistant infections than from cancer.